Research Article
Shen-Zhi-Ling Oral Liquid Improves Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease
Table 1
Characteristics of the patients with Alzheimer’s disease before and after additional treatment.
| | Characteristic | Shen-Zhi-Ling group | | 1st week () | 10th week () | 20th week () | 25th week () |
| | Age (years) | | | Sex (M/F) | 28/17 | | Duration of VD (years) | | | MMSE | | | | | | Huperzine A (μg/d) | (32) | (32) | (31) | (31) | | Aniracetam (mg/d) | (28) | (28) | (29) | (29) | | Memantine hydrochloride (mg/d) | (28) | (30) | (29) | (30) | | Donepezil hydrochloride (mg/d) | (16) | (15) | (15) | (15) | | Rivastigmine (mg/d) | (23) | (14) | (13) | (14) | |
Galantamine reminyl (mg/d) | (26) | (25) | (26) | (26) |
| | Characteristic | Placebo group | | 1st week () | 10th week () | 20th week () | 25th week () |
| | Age (years) | | | Sex (M/F) | 27/19 | | Duration of VD (years) | | | MMSE | | | | | | Huperzine A (g/d) | (34) | (34) | (33) | (32) | | Aniracetam (mg/d) | (26) | (25) | (27) | (27) | |
Memantine hydrochloride (mg/d) | (29) | (30) | (29) | (30) | | Donepezil hydrochloride (mg/d) | (14) | (15) | (16) | (15) | | Rivastigmine (mg/d) | (25) | (24) | (25) | (25) | | Galantamine reminyl (mg/d) | (29) | (29) | (29) | (29) |
|
|
AD: Alzheimer’s disease; MMSE: Mini-Mental State Examination.
|
